Prevalence and Related Risk Factors of Vitamin D Deficiency in Saudi Children with Epilepsy

Background: Vitamin D has a role in the pathogenesis of many medical disorders, especially those of the central nervous system. It is essential in maintaining the bone health of children. However, patients with epilepsy are at high risk of developing vitamin D deficiency due to antiseizure medications (ASMs). Therefore, we aimed to assess the prevalence of vitamin D deficiency and related risk factors in children with epilepsy. Methods: This is the baseline report of a pragmatic, randomized, controlled, open-label trial that assessed the impact of vitamin D supplementation in preventing vitamin D deficiency (NCT03536845). We included children with epilepsy aged 2–16 years who were treated with ASMs from December 2017 to March 2021. Children with preexisting vitamin D metabolism problems, vitamin-D-dependent rickets, malabsorption syndromes, renal disease, and hepatic disease were excluded. The baseline demographic data, anthropometric measurements, seizure types, epilepsy syndromes, ASMs, and seizure control measures were recorded. Blood tests for vitamin D (25-hydroxyvitamin D [25(OH)D), serum calcium, serum phosphorus, and parathyroid hormone levels were performed. Based on vitamin D concentration, patients were categorized as deficient (<50 nmol/L), insufficient (74.9–50 nmol/L), or normal (>75 nmol/L). Results: Of 159 recruited children, 108 (67.92%) had generalized seizures, 44 (27.67%) had focal seizures, and 7 (4.4%) had unknown onset seizures. The number of children receiving monotherapy was 128 (79.0%) and 31 (19.1%) children were receiving polytherapy. The mean vitamin D concentration was 60.24 ± 32.36 nmol/L; 72 patients (45.28%) had vitamin D deficiency and 45 (28.3%) had vitamin D insufficiency. No significant difference in vitamin D concentration was observed between children receiving monotherapy and those receiving polytherapy. The main risk factors of vitamin D deficiency were obesity and receiving enzyme-inducer ASMs. Conclusions: The prevalence of vitamin D deficiency was high among children with epilepsy. Obese children with epilepsy and those on enzyme-inducer ASMs were at increased risk for vitamin D deficiency. Further studies are needed to establish strategies to prevent vitamin D deficiency.

[1]  Carla Lopinto-Khoury,et al.  Impact of carbamazepine on vitamin D levels: A meta-analysis , 2021, Epilepsy Research.

[2]  T. Simasathien,et al.  Hypovitaminosis D and risk factors in pediatric epilepsy children , 2021, BMC Pediatrics.

[3]  I. Santana,et al.  Vitamin D deficiency in a Portuguese epilepsy cohort: who is at risk and how to treat. , 2021, Epileptic disorders : international epilepsy journal with videotape.

[4]  I. Ramadan,et al.  Prevalence and Risk Factors for Vitamin D Insufficiency among Adults with Epilepsy at University Hospital in Jeddah, Saudi Arabia: A Cross Sectional Study , 2021 .

[5]  R. A. Al Khalifah,et al.  Childhood Vitamin D deficiency: Time for policy change , 2021 .

[6]  E. Mello,et al.  Vitamin D deficiency in pediatric patients using antiepileptic drugs: systematic review with meta-analysis , 2020, Jornal de pediatria.

[7]  B. Gidal,et al.  Effects of enzyme-inducing antiseizure medication on vitamin D dosing in adult veterans with epilepsy , 2020, Epilepsy Research.

[8]  N. Shahzad,et al.  Neuroinflammation impact in epileptogenesis and new treatment strategy. , 2019, Behavioural pharmacology.

[9]  N. Jørgensen,et al.  An explorative literature review of the multifactorial causes of osteoporosis in epilepsy , 2019, Epilepsy & Behavior.

[10]  J. Wilmshurst,et al.  Vitamin D abnormalities and bone turn over analysis in children with epilepsy in the Western Cape of South Africa. , 2019, Seizure.

[11]  J. Aloia,et al.  Global prevalence and disease burden of vitamin D deficiency: a roadmap for action in low‐ and middle‐income countries , 2018, Annals of the New York Academy of Sciences.

[12]  Michael F. Holick,et al.  The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention , 2017, Reviews in Endocrine and Metabolic Disorders.

[13]  M. Abbasi,et al.  Epilepsy and vitamin D: a comprehensive review of current knowledge , 2017, Reviews in the neurosciences.

[14]  G. Gartlehner,et al.  Vitamin D deficiency as a risk factor for dementia: a systematic review and meta-analysis , 2017, BMC Geriatrics.

[15]  Adnan Al Shaikh,et al.  Prevalence of Vitamin D Deficiency and Calcium Homeostasis in Saudi Children , 2016, Journal of clinical research in pediatric endocrinology.

[16]  A. R. Mohamed,et al.  Vitamin D deficiency and its risk factors in Malaysian children with epilepsy , 2016, Epilepsia.

[17]  J. Wark,et al.  Osteoporosis Associated with Epilepsy and the Use of Anti-Epileptics—a Review , 2016, Current Osteoporosis Reports.

[18]  H. Cai,et al.  Effect of Antiepileptic Therapy on Serum 25(OH)D3 and 24,25(OH)2D3 Levels in Epileptic Children , 2016, Annals of Nutrition and Metabolism.

[19]  D. Thickett,et al.  Optimal Vitamin D Supplementation Levels for Cardiovascular Disease Protection , 2015, Disease markers.

[20]  B. Ekici,et al.  Epilepsy treatment by sacrificing vitamin D , 2014, Expert review of neurotherapeutics.

[21]  C. Y. Fong,et al.  Vitamin D Deficiency Among Children With Epilepsy in South Queensland , 2014, Journal of child neurology.

[22]  J. Sugimoto,et al.  The Global Hidden Hunger Indices and Maps: An Advocacy Tool for Action , 2013, PloS one.

[23]  C. Gordon,et al.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[24]  JoAnn E. Manson,et al.  The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know , 2010, The Journal of clinical endocrinology and metabolism.

[25]  P. Knekt,et al.  Serum vitamin D and the risk of Parkinson disease. , 2010, Archives of neurology.

[26]  R. Shellhaas,et al.  Vitamin D and bone health among children with epilepsy. , 2010, Pediatric neurology.

[27]  M. Misra,et al.  Vitamin D Deficiency in Children and Its Management: Review of Current Knowledge and Recommendations , 2008, Pediatrics.

[28]  A. Sadovnick,et al.  Vitamin D intake and incidence of multiple sclerosis , 2004, Neurology.

[29]  F. Dall’ara,et al.  Vitamin D and systemic lupus erythematous: a review of immunological and clinical aspects. , 2018, Clinical and experimental rheumatology.

[30]  M. M. A. Madhusmita Misra,et al.  Vitamin D Deficiency in Children and Its Management: Review of Current Knowledge and Recommendations , 2008 .

[31]  A F Roche,et al.  CDC growth charts: United States. , 2000, Advance data.